Sort
78,016 grants matching “breast cancer”
Communication and Dissemination Core
$439,539Lawrence Chin-I An · University Of Michigan At Ann Arbor · P01 · FY2014 · CA
Developmental Funds
$439,520Juanita L Merchant · University Of Arizona · P30 · FY2024 · CA
Developmental Funds
$439,520Juanita L Merchant · University Of Arizona · P30 · FY2023 · CA
Use of CTEP portfolio compounds to counteract phenotype conversion in GBM
$439,519Frank Pajonk · University Of California Los Angeles · R01 · FY2024 · CA
PKC Alpha as a Marker for Logical Therapeutic Approaches to Breast Cancer
$439,517Debra Tonetti · University Of Illinois At Chicago · R01 · FY2010 · CA
Scottsdale Community Clinical Oncology Program
$439,512Mayo Clinic Coll Of Med, Mayo Clinic Az · U10 · FY2001 · CA
Cost Effectiveness of the Rural Breast Cancer Survivor Intervention Package
$439,500Michael Patrick McNees · University Of Alabama At Birmingham · R01 · FY2009 · NR
Combinational Environmental Chemicals Altering Susceptibility for Mammary Cancer
$439,500Coral Lamartiniere · University Of Alabama At Birmingham · U01 · FY2010 · ES
Evaluating a simple nanochemistry for lineage-targeted drug delivery
$439,500Shunji Egusa · University Of North Carolina Charlotte · R15 · FY2018 · GM
Repair &Prevention of DNA Damage &Breast Cancer Risk
$439,496New York University School Of Medicine · R01 · FY2004 · CA
Nanoparticle contrast agents for earlier breast cancer detection
$439,409David Peter Cormode · University Of Pennsylvania · R01 · FY2022 · CA
Views of Privacy of Genetic Information
$439,404New York State Psychiatric Institute · R01 · FY2002 · HG
The Metastatic Cascade: Macrophages Lead the Way
$439,400Jeffrey W. Pollard · Albert Einstein College Of Medicine, Inc · R01 · FY2017 · CA
The Metastatic Cascade: Macrophages Lead the Way
$439,400Jeffrey W. Pollard · Albert Einstein College Of Medicine, Inc · R01 · FY2016 · CA
The Metastatic Cascade: Macrophages Lead the Way
$439,399Jeffrey W. Pollard · Albert Einstein College Of Medicine · R01 · FY2015 · CA
Accurate MR-based PET Attenuation Correction for Quantitative Clinical Trials
$439,398Raymond F Muzic · Case Western Reserve University · R01 · FY2019 · CA
Clinical Pharmacology and Drug-Drug Interactions in HIV-Associated Malignancy
$439,362William Douglas Figg · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Exosome secretion in breast cancer progression
$439,356Alissa M Weaver · Vanderbilt University · R01 · FY2019 · CA
Defining Response and Resistance to PI3K and AR inhibition in Prostate Cancer
$439,351Brett Stewart Carver · Sloan-Kettering Inst Can Research · R01 · FY2016 · CA
Defining Response and Resistance to PI3K and AR inhibition in Prostate Cancer
$439,351Brett Stewart Carver · Sloan-Kettering Inst Can Research · R01 · FY2018 · CA
Defining Response and Resistance to PI3K and AR inhibition in Prostate Cancer
$439,351Brett Stewart Carver · Sloan-Kettering Inst Can Research · R01 · FY2015 · CA
Defining Response and Resistance to PI3K and AR inhibition in Prostate Cancer
$439,351Brett Stewart Carver · Sloan-Kettering Inst Can Research · R01 · FY2017 · CA
In Vivo Studies of the Epileptic Hippocampus
$439,337Jerome None Engel · University Of California Los Angeles · R01 · FY2012 · NS
FULL-RING ULTRASOUND AND ENHANCED PHOTOACOUSTIC TOMOGRAPHY SYSTEM: TOWARD MULTIMODAL, NONIONIZING, AND POINT-OF-CARE BREAST CANCER IMAGING
$439,322Wayne State University · · FY2018 · Defense Health Agency
The Women In Steady Exercise Research (WISER) SurwVor Trial
$439,320Kathryn H. Schmitz · University Of Pennsylvania · U54 · FY2014 · CA